Literature DB >> 4163515

Antinuclear factors in synovial fluids.

R N MacSween, T K Dalakos, M K Jasani, M E Wilson, J A Boyle, W W Buchanan, R B Goudie.   

Abstract

Mesh：

Substances：

Year:  1967        PMID： 4163515     DOI： 10.1016/s0140-6736(67)91244-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  A clinico-immunological study of serum and synovial fluid antinuclear factors in rheumatoid arthritis and other arthritides.

Authors:  R N MacSween; T G Dalakos; M K Jasani; J A Boyle; W W Buchanan; R B Goudie
Journal:  Clin Exp Immunol       Date:  1968-01       Impact factor: 4.330

2.  Ankylosing spondylitis and auto-immunity.

Authors:  G O Cowan
Journal:  Postgrad Med J       Date:  1973-09       Impact factor: 2.401

3.  Granulocyte-specific antinuclear factors in serum and synovial fluid in rheumatoid arthritis.

Authors:  P Elling; H Graudal; V Faber
Journal:  Ann Rheum Dis       Date:  1968-05       Impact factor: 19.103

Review 4.  HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27?

Authors:  J H Ringrose
Journal:  Ann Rheum Dis       Date:  1999-10       Impact factor: 19.103

5.  Anti-Sm and anti-DNA antibodies in paired serum and synovial fluid samples from patients with SLE.

Authors:  K M Pollard; L J Furphy; J Webb
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.